e-learning
resources
London 2016
Monday, 05.09.2016
Microbiological issues and translational research in respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Macrolide-resistant mycoplasma pneumoniae in respiratory tract infection and its clinical relevance
Pornanan Domthong (Bangkok, Thailand), Pornanan Domthong, Uthumporn Domthong, Poonapong Hansiriphan, Virissorn Wongsrichanalai, Sudaluck Tanyaharn, Varunya Wutthichan, Patumporn Jian-umpunkul, Anan Wattanathum
Source:
International Congress 2016 – Microbiological issues and translational research in respiratory infections
Session:
Microbiological issues and translational research in respiratory infections
Session type:
Thematic Poster
Number:
2614
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Pornanan Domthong (Bangkok, Thailand), Pornanan Domthong, Uthumporn Domthong, Poonapong Hansiriphan, Virissorn Wongsrichanalai, Sudaluck Tanyaharn, Varunya Wutthichan, Patumporn Jian-umpunkul, Anan Wattanathum. Macrolide-resistant mycoplasma pneumoniae in respiratory tract infection and its clinical relevance. Eur Respir J 2016; 48: Suppl. 60, 2614
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Related content which might interest you:
Urinary antigen of S. pneumoniae in the microbiological diagnosis of lower respiratory tract infections
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Antibiotic resistance genotype trend and association with host clinical characteristics in respiratory isolates of
streptococcus pneumoniae
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014
Atypical pathogens and respiratory tract infections
Source: Eur Respir J 2004; 24: 171-182
Year: 2004
Molecular characterisation and clinical presentation of Mycoplasma pneumoniae lower respiratory tract infections in children
Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes
Year: 2018
Klebsiella respiratory infection community acquired
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013
Clinical relevance of
C. pseudodiphtheriticum
in lower respiratory tract specimens
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Streptococcus pneumoniae infection is an independent cause of cardiac rhythm alteration in community-acquired pneumonia
Source: International Congress 2015 – Prognostic factors in pneumonia: from clinical observations to experimental models
Year: 2015
Resistance of respiratory tract Streptococcus pneumoniae strains
Source: Eur Respir J 2002; 20: Suppl. 38, 358s
Year: 2002
Chlamydia pneumoniae and Mycoplasma pneumonia infection in children respiratory diseases
Source: Virtual Congress 2021 – Acute paediatric respiratory infections
Year: 2021
Distribution of respiratory manifestations during the
Chlamidiae psittaci
infections
Source: Eur Respir J 2005; 26: Suppl. 49, 409s
Year: 2005
Monitoring opportunistic microflora in patients with HIV infection and highlighting the significance of Streptococcus gr. viridans in the development of lower respiratory tract infections
Source: Virtual Congress 2020 – Translational science in respiratory infections
Year: 2020
The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
Clinical and radiological features can help predict Mycoplasma pneumoniae lower respiratory tract infection in children
Source: Virtual Congress 2021 – Acute paediatric respiratory infections
Year: 2021
Occurrence of Chlamydia trachomatis and Chlamydia pneumoniae in paediatric respiratory infections
Source: Eur Respir J 2009; 33: 360-367
Year: 2009
Respiratory commensal streptococcus spp do not modulate the outcome of pseudomonas aeruginosa infection in vivo
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016
Community-acquired pneumonia (CAP) caused by
mycoplasma pneumoniae
or
chlamydophila pneumoniae
in children: Are there reliable signs/symptoms for clinical diagnostics?
Source: Annual Congress 2013 –The burden of respiratory infections in children
Year: 2013
Community-acquired pneumonia in Europe: causative pathogens and resistance patterns
Source: Eur Respir J 2002; 20: 20S-27S
Year: 2002
The impact of antibiotic resistance in the management of lower respiratory tract infections
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=131
Year: 2004
Is Chlamydia pneumoniae an important pathogen in patients with community-acquired pneumonia?
Source: Eur Respir J 2003; 21: 741-742
Year: 2003
Chlamydia species as a cause of community-acquired pneumonia in Canada
Source: Eur Respir J 2003; 21: 779-784
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept